Characterization of Soluble Hepatitis C Virus RNA-Dependent RNA Polymerase Expressed in Escherichia coli

Por Ferrari, Eric, Wright-Minogue, Jacquelyn, Fang, Jane W. S., Baroudy, Bahige M., Lau, Johnson Y. N., Hong, Zhi
Publicado em 1999

Anti-Human Immunodeficiency Virus Interactions of SCH-C (SCH 351125), a CCR5 Antagonist, with Other Antiretroviral Agents In Vitro

Por Tremblay, Cécile L., Giguel, Françoise, Kollmann, Christopher, Guan, Yongbiao, Chou, Ting-Chao, Baroudy, Bahige M., Hirsch, Martin S.
Publicado em 2002

Hepatitis C Virus Internal Ribosome Entry Site (IRES) Stem Loop IIId Contains a Phylogenetically Conserved GGG Triplet Essential for Translation and IRES Folding

Por Jubin, Ronald, Vantuno, Nicole E., Kieft, Jeffrey S., Murray, Michael G., Doudna, Jennifer A., Lau, Johnson Y. N., Baroudy, Bahige M.
Publicado em 2000

Virus-Specific Cofactor Requirement and Chimeric Hepatitis C Virus/GB Virus B Nonstructural Protein 3

Por Butkiewicz, Nancy, Yao, Nanhua, Zhong, Weidong, Wright-Minogue, Jacquelyn, Ingravallo, Paul, Zhang, Rumin, Durkin, James, Standring, David N., Baroudy, Bahige M., Sangar, David V., Lemon, Stanley M., Lau, Johnson Y. N., Hong, Zhi
Publicado em 2000

The Differential Sensitivity of Human and Rhesus Macaque CCR5 to Small-Molecule Inhibitors of Human Immunodeficiency Virus Type 1 Entry Is Explained by a Single Amino Acid Differen...

Por Billick, Erika, Seibert, Christoph, Pugach, Pavel, Ketas, Tom, Trkola, Alexandra, Endres, Michael J., Murgolo, Nicholas J., Coates, Elizabeth, Reyes, Gregory R., Baroudy, Bahige M., Sakmar, Thomas P., Moore, John P., Kuhmann, Shawn E.
Publicado em 2004

Genetic and Phenotypic Analyses of Human Immunodeficiency Virus Type 1 Escape from a Small-Molecule CCR5 Inhibitor

Por Kuhmann, Shawn E., Pugach, Pavel, Kunstman, Kevin J., Taylor, Joann, Stanfield, Robyn L., Snyder, Amy, Strizki, Julie M., Riley, Janice, Baroudy, Bahige M., Wilson, Ian A., Korber, Bette T., Wolinsky, Steven M., Moore, John P.
Publicado em 2004

Genetic and Phenotypic Analyses of Human Immunodeficiency Virus Type 1 Escape from a Small-Molecule CCR5 Inhibitor

Por Kuhmann, Shawn E., Pugach, Pavel, Kunstman, Kevin J., Taylor, Joann, Stanfield, Robyn L., Snyder, Amy, Strizki, Julie M., Riley, Janice, Baroudy, Bahige M., Wilson, Ian A., Korber, Bette T., Wolinsky, Steven M., Moore, John P.
Publicado em 2004

HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use

Por Trkola, Alexandra, Kuhmann, Shawn E., Strizki, Julie M., Maxwell, Elizabeth, Ketas, Tom, Morgan, Tom, Pugach, Pavel, Xu, Serena, Wojcik, Lisa, Tagat, Jayaram, Palani, Anandan, Shapiro, Sherry, Clader, John W., McCombie, Stuart, Reyes, Gregory R., Baroudy, Bahige M., Moore, John P.
Publicado em 2002

Discovery and Characterization of Vicriviroc (SCH 417690), a CCR5 Antagonist with Potent Activity against Human Immunodeficiency Virus Type 1

Por Strizki, Julie M., Tremblay, Cecile, Xu, Serena, Wojcik, Lisa, Wagner, Nicole, Gonsiorek, Waldemar, Hipkin, R. William, Chou, Chuan-Chu, Pugliese-Sivo, Catherine, Xiao, Yushi, Tagat, Jayaram R., Cox, Kathleen, Priestley, Tony, Sorota, Steve, Huang, Wei, Hirsch, Martin, Reyes, Gregory R., Baroudy, Bahige M.
Publicado em 2005

SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo

Por Strizki, Julie M., Xu, Serena, Wagner, Nicole E., Wojcik, Lisa, Liu, Jia, Hou, Yan, Endres, Michael, Palani, Anandan, Shapiro, Sherry, Clader, John W., Greenlee, William J., Tagat, Jayaram R., McCombie, Stuart, Cox, Kathleen, Fawzi, Ahmad B., Chou, Chuan-Chu, Pugliese-Sivo, Catherine, Davies, Liza, Moreno, Mary E., Ho, David D., Trkola, Alexandra, Stoddart, Cheryl A., Moore, John P., Reyes, Gregory R., Baroudy, Bahige M.
Publicado em 2001